Dr. Von Holzen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 High Park Ave
Goshen, IN 46526Phone+1 574-364-2888Fax+1 574-364-2480
Education & Training
University of Zurich Faculty of MedicineClass of 1998
Certifications & Licensure
IN State Medical License 2014 - 2025
PA State Medical License 2008 - 2024
Publications & Presentations
PubMed
- 29 citationsDual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancer.Niranjan Awasthi, David Kronenberger, Alexis Stefaniak, Sazzad Hassan, Urs von Holzen
Cancer Letters. 2019-09-10 - 33 citationsOX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancerBenjamin Weixler, Eleonora Cremonesi, Roberto Sorge, Manuele G. Muraro, Tarik Delko
Oncotarget. 2015-10-01 - 13 citationsLow Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal ...Silvio Däster, Serenella Eppenberger-Castori, Valentina Mele, Hannah Maria Schäfer, Lukas Schmid
Frontiers in Medicine. 2020-04-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
